Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Psychiatry|May 1, 1992
Weight gain among schizophrenic patients treated with clozapineJ S Lamberti, T Bellnier, S B Schwarzkopf
Journal of Psychiatric Practice|July 2, 2005
Seven keys to relapse prevention in schizophreniaJ S Lamberti
Schizophrenia Bulletin|January 1, 1995
Prodromal symptoms and relapse prevention in schizophreniaM I Herz, J S Lamberti
The Psychiatric Quarterly|July 31, 1998
Intensive Psychiatric Rehabilitation Treatment (IPRT): an overview of a new programJ S Lamberti, V Melburg, N Madi
Biological Psychiatry|June 1, 1993
Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibitionS B Schwarzkopf, J S Lamberti, D A Smith
The Journal of Clinical Psychiatry|June 1, 1995
Filgrastim treatment of three patients with clozapine-induced agranulocytosisJ S Lamberti, T J Bellnier, S B Schwarzkopf, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1993
Within-session changes in sensory gating assessed by P50 evoked potentials in normal subjectsJ S Lamberti, S B Schwarzkopf, N Boutros, et al.
Biological Psychiatry|February 15, 1990
Visual evoked potential correlates of positive/negative symptoms in schizophreniaS B Schwarzkopf, J S Lamberti, M Jiminez, et al.
The Psychiatric Quarterly|April 11, 2001
The mentally ill in jails and prisons: towards an integrated model of preventionJ S Lamberti, R L Weisman, S B Schwarzkopf, et al.
Pageof 2